1. Biological significance of autologous tumor-killing activity and its induction therapy

   • Atsushi Uchida

   Review Pages: 75 - 83

2. Direct and indirect effects of human interferon α on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects

   • Hideyasu Matsuyama
   • Satoru Yoshihiro
   • Katsusuke Naito

   Original Articles Pages: 84 - 88

3. Two tumor models of curative adoptive chemoimmunotherapy using tumor-infiltrated spleen cells with potent antitumor cytotoxicity stimulated by antigen-sharing tumors

   • Maribeth Laude
   • Katherine L. Russo
   • Sheldon Dray

   Original Articles Pages: 89 - 96

4. Protective effect of interferon β on human T cell leukaemia virus type I infection of CD4⁺ T cells isolated from human cord blood

   • Beatrice Macchi
   • Isabella Faraoni
   • Enzo Bonmassar

   Original Articles Pages: 97 - 104

5. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro

   • Andreas Thanhäuser
   • Andreas Böhle
   • Artur J. Ulmer

   Original Articles Pages: 105 - 111

6. Interactions between interferon γ and retinoic acid with transforming growth factor β in the induction of immune recognition molecules

   • Richard Darley
   • Alan Morris
   • Wendy Bateman

   Original Articles Pages: 112 - 118

7. Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer

   • Marco Scudeletti
   • Gilberto Filaci
   • Francesco Puppo

   Original Articles Pages: 119 - 124

8. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells

   • G. Heuff
   • H. S. A. Oldenburg
   • S. Meyer

   Original Articles Pages: 125 - 130

9. Emergence of non-major-histocompatibility-complex-restricted lytic CD8⁺ cells in the blood of nasopharyngeal carcinoma patients

   • M. Lakhdar
   • H. Thameur
   • A. Ladgham

   Original Articles Pages: 131 - 139

10. Activity of a short course of interferon α for metastatic renal cell carcinoma — a phase-2 study

    • Raymond P. Abratt
    • Alan R. Pontin
    • Helen S. Ball

    Short Communication Pages: 140 - 141